MedX Health Corp
MDX.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.12% | -26.06% | 47.89% | -16.01% | -2.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.12% | -26.06% | 47.89% | -16.01% | -2.27% |
| Cost of Revenue | 87.78% | 158.10% | 71.98% | 42.22% | -20.36% |
| Gross Profit | 34.94% | -315.30% | 8.00% | -68.41% | 40.08% |
| SG&A Expenses | -23.29% | 265.54% | 97.93% | 22.16% | 65.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.05% | 172.06% | 73.84% | 20.06% | 43.81% |
| Operating Income | 21.37% | -284.94% | -78.66% | -25.16% | -50.37% |
| Income Before Tax | 20.96% | -88.77% | -83.16% | -40.47% | -61.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.96% | -88.77% | -83.16% | -40.47% | -61.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.96% | -88.77% | -83.16% | -40.47% | -61.87% |
| EBIT | 21.37% | -284.94% | -78.66% | -25.16% | -50.37% |
| EBITDA | 20.67% | -656.78% | -80.37% | -25.63% | -51.30% |
| EPS Basic | 34.15% | -62.07% | -63.16% | -26.92% | -57.69% |
| Normalized Basic EPS | 34.62% | -44.44% | -58.33% | -25.00% | -62.50% |
| EPS Diluted | 34.15% | -62.07% | -63.16% | -26.92% | -57.69% |
| Normalized Diluted EPS | 34.62% | -44.44% | -58.33% | -25.00% | -62.50% |
| Average Basic Shares Outstanding | 20.42% | 18.83% | 11.78% | 9.87% | 3.95% |
| Average Diluted Shares Outstanding | 20.42% | 18.83% | 11.78% | 9.87% | 3.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |